Shopping Cart 0
Cart Subtotal
USD 0

Global Checkpoint Inhibitors for Treating Cancer Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2980

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5960

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5960
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Snapshot

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the brakes on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.

The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Checkpoint Inhibitors for Treating Cancer by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

PD-1 inhibitors

PD-L1 inhibitors

CTLA-4 inhibitors

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Bristol-Myers Squibb(BMS)

Merck

Roche

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Melanoma treatment

Bladder cancer treatment

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Overview

1.1 Checkpoint Inhibitors for Treating Cancer Industry

1.1.1 Overview

1.1.2 Development of Checkpoint Inhibitors for Treating Cancer

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Checkpoint Inhibitors for Treating Cancer Market by Type

3.1 By Type

3.1.1 PD-1 inhibitors

3.1.2 PD-L1 inhibitors

3.1.3 CTLA-4 inhibitors

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Checkpoint Inhibitors for Treating Cancer Bristol-Myers Squibb(BMS) (Company Profile, Sales Data etc.)

4.2 Merck (Company Profile, Sales Data etc.)

4.3 Roche (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Melanoma treatment

6.1.2 Demand in Bladder cancer treatment

6.1.3 Demand in Others

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2013-2018, by Type, in USD Million

Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2013-2018, by Type, in Volume

Figure North America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018

Figure Europe Checkpoint Inhibitors for Treating Cancer Market Market Concentration, in 2018

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer MMarket Concentration, in 2018

Figure South America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018

Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2013-2018, in USD Million

Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2013-2018, in Volume

Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2013-2018, in USD Million

Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2013-2018, in Volume

Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2013-2018, in USD Million

Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2013-2018, in Volume

Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million

Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume

Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million

Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume

Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million

Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Checkpoint Inhibitors for Treating Cancer

Table Application Segment of Checkpoint Inhibitors for Treating Cancer

Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2024, by Application, in USD Million

Table Major Company List of PD-1 inhibitors

Table Major Company List of PD-L1 inhibitors

Table Major Company List of CTLA-4 inhibitors

Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Type, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Type, in Volume

Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Type, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Type, in Volume

Table Bristol-Myers Squibb(BMS) Overview List

Table Checkpoint Inhibitors for Treating Cancer Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Overview List

Table Checkpoint Inhibitors for Treating Cancer Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Overview List

Table Checkpoint Inhibitors for Treating Cancer Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue 2013-2018, by Company, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share, by Company, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume 2013-2018, by Company, in Volume

Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2019-2024, by Application, in USD Million

Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2019-2024, by Application, in Volume

Table Checkpoint Inhibitors for Treating Cancer Production 2013-2018, by Region, in USD Million

Table Checkpoint Inhibitors for Treating Cancer Production 2013-2018, by Region, in Volume

Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Region, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2013-2018, by Region, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Region, in Volume

Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2013-2018, by Region, in Volume

Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million

Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume

Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million

Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume

Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million

Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume

Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Region, in USD Million

Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Snapshot

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the brakes on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.

The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Checkpoint Inhibitors for Treating Cancer by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

PD-1 inhibitors

PD-L1 inhibitors

CTLA-4 inhibitors

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Bristol-Myers Squibb(BMS)

Merck

Roche

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Melanoma treatment

Bladder cancer treatment

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Scope

Table of Contents

1 Industry Overview

1.1 Checkpoint Inhibitors for Treating Cancer Industry

1.1.1 Overview

1.1.2 Development of Checkpoint Inhibitors for Treating Cancer

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Checkpoint Inhibitors for Treating Cancer Market by Type

3.1 By Type

3.1.1 PD-1 inhibitors

3.1.2 PD-L1 inhibitors

3.1.3 CTLA-4 inhibitors

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Checkpoint Inhibitors for Treating Cancer Bristol-Myers Squibb(BMS) (Company Profile, Sales Data etc.)

4.2 Merck (Company Profile, Sales Data etc.)

4.3 Roche (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Melanoma treatment

6.1.2 Demand in Bladder cancer treatment

6.1.3 Demand in Others

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2013-2018, by Type, in USD Million

Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2013-2018, by Type, in Volume

Figure North America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018

Figure Europe Checkpoint Inhibitors for Treating Cancer Market Market Concentration, in 2018

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer MMarket Concentration, in 2018

Figure South America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018

Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2013-2018, in USD Million

Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2013-2018, in Volume

Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2013-2018, in USD Million

Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2013-2018, in Volume

Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2013-2018, in USD Million

Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2013-2018, in Volume

Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million

Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume

Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million

Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume

Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million

Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Checkpoint Inhibitors for Treating Cancer

Table Application Segment of Checkpoint Inhibitors for Treating Cancer

Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2024, by Application, in USD Million

Table Major Company List of PD-1 inhibitors

Table Major Company List of PD-L1 inhibitors

Table Major Company List of CTLA-4 inhibitors

Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Type, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Type, in Volume

Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Type, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Type, in Volume

Table Bristol-Myers Squibb(BMS) Overview List

Table Checkpoint Inhibitors for Treating Cancer Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Overview List

Table Checkpoint Inhibitors for Treating Cancer Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Overview List

Table Checkpoint Inhibitors for Treating Cancer Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue 2013-2018, by Company, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share, by Company, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume 2013-2018, by Company, in Volume

Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2019-2024, by Application, in USD Million

Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2019-2024, by Application, in Volume

Table Checkpoint Inhibitors for Treating Cancer Production 2013-2018, by Region, in USD Million

Table Checkpoint Inhibitors for Treating Cancer Production 2013-2018, by Region, in Volume

Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Region, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2013-2018, by Region, in USD Million

Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Region, in Volume

Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2013-2018, by Region, in Volume

Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million

Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume

Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million

Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume

Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million

Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume

Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Region, in USD Million

Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com
chat_bubbleLet's Chat